North American Nuclear Medicine Industry Overview

 The North American Nuclear Medicine market size is expected to reach USD 2.7 billion by 2024, registering a CAGR of 4.1 % over the forecast period, according to a study conducted by MarketsandMarkets. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108

By type, the SPECT radiopharmaceutical segment is expected to account for the largest share of the diagnostic nuclear medicine market in 2019

Based on type, the North American nuclear medicine market is categorized into diagnostic and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is further categorized into SPECT and PET radiopharmaceuticals.

By application, the PET oncology application segment is expected to account for the largest share of the market in 2019

Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The PET applications segment is further segmented into oncology, cardiology, and neurology, among others.

The US to dominate the market

The North American nuclear medicine market is segmented into the US and Canada, based on country. The US is expected to account for the largest share and also register the highest CAGR during the forecast period.

Some prominent players in the global North American Nuclear Medicine market include:

The prominent players in the global North American nuclear medicine market include Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108

North American Nuclear Medicine Market Segmentation

MarketsandMarkets has segmented the North American Nuclear Medicine market based on Therapeutic Type, application, and region:

By Type

• Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
    • Technetium-99m
    • Thallium-201
    • Gallium-67
    • Iodine-123
    • Other SPECT Isotopes
  • PET Radiopharmaceuticals
    • F-18
    • Ru-82
    • Other PET Isotopes
• Therapeutic Nuclear Medicine
  • Alpha Emitters
    • Ra-223
  • Beta Emitters
    • Iodine-131
    • Yttrium-90
    • Samarium-153
    • Lutetium-177
    • Rhenium-186
    • Other Beta Emitters
  • Brachytherapy Isotopes
    • Iodine-125
    • Palladium-103
    • Cesium-131
    • Iridium-192
    • Other Brachytherapy Isotopes

By Application

• Diagnostic Applications
  • SPECT Applications
    • Cardiology
    • Bone Scans
    • Thyroid Applications
    • Pulmonary Scans
    • Other SPECT Applications
  • PET Applications
    • Oncology
    • Cardiology
    • Neurology
    • Other PET Applications
  • Therapeutic Applications
    • Thyroid Indications
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Indications

By Procedural Volume Assessment

• Diagnostic Procedures
  • SPECT Procedures
  • PET Procedures
• Therapeutic Procedures
  • Beta Emitter Procedures
  • Alpha Emitter Procedures
  • Brachytherapy Procedures

By Country

• North America
  • US
  • Canada